Influence of real-world characteristics on outcomes for patients with methicillin-resistant Staphylococcal skin and soft tissue infections: A multi-country medical chart review in Europe

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Nathwani, Dilip ^a   Eckmann, Christian ^b   Lawson, Wendy ^c   Solem, Caitlyn T ^d   Corman, Shelby ^d   Stephens, Jennifer M ^d   Macahilig, Cynthia ^e   Simoneau, Damien ^f   Chambers, Richard ^f   Li, Jim Z ^f   Haider, Seema ^f  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^d PHARMERIT INTERNATIONAL   (United States)

^e Medical Data Analytics   (United States)

^f PFIZER INC   (United States)

Author keywords

Antibiotic therapy; Clinical criteria; IV to oral antibiotic switch; Length of stay

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; COMPLICATED SKIN AND SOFT TISSUE INFECTION; DEMENTIA; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EUROPE; FEMALE; HEALTH CARE UTILIZATION; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; AGED; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; PENICILLIN RESISTANCE; PHYSIOLOGY; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; EUROPE; FEMALE; HUMANS; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS;

EID: 84907034181     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-476     Document Type: Article

References (27)

1. Mladovsky P, Srivastava D, Cylus J, Karanikolos M, Evetovits T, Thomson S, McKee M. Health Policy Responses to the Financial Crisis in Europe. 2012, http://www.euro.who.int/en/data-and-evidence/evidence-informed-policy-making/publications/2012/health-policy-responses-to-the-financial-crisis-in-europe.
2. Edelsberg J, Berger A, Weber DJ, Mallick R, Kuznik A, Oster G. Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol 2008, 29(2):160-169. 10.1086/526444, 18179372.
3. Hatoum HT, Akhras KS, Lin SJ. The attributable clinical and economic burden of skin and skin structure infections in hospitalized patients: a matched cohort study. Diagn Microbiol Infect Dis 2009, 64(3):305-310. 10.1016/j.diagmicrobio.2009.02.005, 19501792.
4. Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM. Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol 2007, 28(11):1290-1298. 10.1086/520743, 17926281.
5. Bamford KB, Desai M, Aruede MJ, Lawson W, Jacklin A, Franklin BD. Patients' views and experience of intravenous and oral antimicrobial therapy: room for change. Injury 2011, 42(Suppl 5):S24-S27.
6. Borner M, Scheithauer W, Twelves C, Maroun J, Wilke H. Answering patients' needs: oral alternatives to intravenous therapy. Oncologist 2001, 6(Suppl 4):12-16.
7. Antimicrobial Resistance Surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2012, http://www.ecdc.europa.eu/en/publications/publications/antimicrobial-resistance-surveillance-europe-2011.pdf.
8. Sader HS, Farrell DJ, Jones RN. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents 2010, 36(1):28-32. 10.1016/j.ijantimicag.2010.03.016, 20444576.
9. Hospitals in Europe: Healthcare Data. 2011, http://www.hope.be/03activities/quality_eu-hospitals/eu_country_profiles/00-hospitals_in_europe-synthesis_vs2011-06.pdf.
10. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44(2):159-177. 10.1086/510393, 17173212.
11. Goff DA, Bauer KA, Reed EE, Stevenson KB, Taylor JJ, West JE. Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?. Clin Infect Dis 2012, 55(4):587-592. 10.1093/cid/cis494, 22615329.
12. Eckmann C, Lawson W, Nathwani D, Solem CT, Stephens JM, Macahilig C, Simoneau D, Hajek P, Charbonneau C, Chambers R, Li JZ, Haider S. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: A plea for implementation of early switch and early discharge criteria. Int J Antimicrob Agents 2014, 44(1):56-64. 10.1016/j.ijantimicag.2014.04.007, 24928311.
13. Nathwani D, Eckmann C, Lawson W, Stephens JM, Macahilig C, Solem CT, Simoneau D, Chambers R, Li JZ, Haider S. Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections. Clin Microbiol Infect 2014, doi:10.1111/1469-0691.12632. [Epub ahead of print].
14. Chapman AL, Dixon S, Andrews D, Lillie PJ, Bazaz R, Patchett JD. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009, 64(6):1316-1324. 10.1093/jac/dkp343, 19767623.
15. Cunha BA. Oral antibiotic therapy of serious systemic infections. Med Clin North Am 2006, 90(6):1197-1222. 10.1016/j.mcna.2006.07.009, 17116444.
16. Desai M, Franklin BD, Holmes AH, Trust S, Richards M, Jacklin A, Bamford KB. A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay. BMC Infect Dis 2006, 6:94. 10.1186/1471-2334-6-94, 1513579, 16762061.
17. Matthews PC, Conlon CP, Berendt AR, Kayley J, Jefferies L, Atkins BL, Byren I. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007, 60(2):356-362. 10.1093/jac/dkm210, 17566002.
18. Nathwani D, Moitra S, Dunbar J, Crosby G, Peterkin G, Davey P. Skin and soft tissue infections: development of a collaborative management plan between community and hospital care. Int J Clin Pract 1998, 52(7):456-460.
19. Parodi S, Rhew DC, Goetz MB. Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections. J Manag Care Pharm 2003, 9(4):317-326.
20. Seaton RA, Bell E, Gourlay Y, Semple L. Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone. J Antimicrob Chemother 2005, 55(5):764-767. 10.1093/jac/dki092, 15772137.
21. Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Gainer RB, Kunkel MJ, Yancey RW, Williams DN. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004, 38(12):1651-1672.
22. Dryden M, Saeed K, Townsend R, Winnard C, Bourne S, Parker N, Coia J, Jones B, Lawson W, Wade P, Howard P, Marshall S. Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management. J Antimicrob Chemother 2012, 67(9):2289-2296. 10.1093/jac/dks193, 22623629.
23. Gray A, Dryden M, Charos A. Antibiotic management and early discharge from hospital: an economic analysis. J Antimicrob Chemother 2012, 67(9):2297-2302. 10.1093/jac/dks194, 22623630.
24. Lim SC, Doshi V, Castasus B, Lim JKH, Mamun K. Factors causing delay in discharge of elderly patients in an acute care hospital. Ann Acad Med Singapore 2006, 35:27-32.
25. Hensher M, Fulop N, Coast J, Jefferys E. The hospital of the future. Better out than in? Alternatives to acute hospital care. BMJ Correct 1999, 319(7217):1127-1130.
26. Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clinic Proc Mayo Clinic 2011, 86(2):156-167.
27. Eckmann C, Dryden M. Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur J Med Res 2010, 15(12):554-563. 3352104, 21163730.